TIXiMED
CompanyUnited States
TIXiMED develops one asset, in phase 1 (TIX100 in health adult subjects). Mostly small molecule acting on lipid and ceramide metabolism; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 1
- 1
- Trial
- 0
- Signals
Pipeline
1Investigational oral therapeutic for overweight and obesity.
Phase 1, Small molecule, Lipid and ceramide metabolism, health adult subjects, obesity & overweight
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Signals2
- Similar companies6